In a research note issued on Thursday, Roth Capital analyst Joe Reagor maintained a Buy rating on Solitario Exploration & Royalty (XPL) with …
In a research note released today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Stemline Therapeutics, Inc. (STML) and a price target of $62.
In a research note issued today, Roth Capital analyst Dave King raised his price target on Sequential Brands Group, Inc. (SQBG) from $10.
In a research note released this morning, Roth Capital analyst Philip Shen maintained a Buy rating on shares of Hudson Technologies Inc. (HDSN) and a price target of $6, representing a …
In a research note released today, Roth Capital analyst Dave King reaffirms a Neutral rating on Zagg Inc. (ZAGG) with a price target of …
Nanosphere, Inc. (NSPH) announced this morning that it received FDA clearance for the bacterial portion of its enteric pathogen (EP) test.
In a report released this morning, Roth Capital analyst Richard Baldry initiated coverage on Concur Technologies (CNQR) with a Buy rating and a $130 price …
In a research note issued this morning, Roth Capital analyst Krishna Shankar maintained a Buy rating and $3.50 price target on QuickLogic Corp (QUIK) following today’s news that Audience (ADNC) signed a definitive …
In a research note issued today, Roth Capital analyst Chris Lewis reiterated a “Buy” rating on Align Technology (ALGN) and a price target of $66 following Danahers Corporation’s (DHR) …
In a report issued today, Roth Capital analyst Dave King maintained a “Buy” rating on LeapFrog Enterprises Inc. (LF) and a price target of $7.
